243 related articles for article (PubMed ID: 2429668)
21. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
22. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia].
Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684
[TBL] [Abstract][Full Text] [Related]
23. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and cell cycle perturbations in methotrexate-treated cells.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394
[TBL] [Abstract][Full Text] [Related]
25. [Use of purine rescue pathways by L1210 cells exposed to methotrexate in vitro].
Buesa JM
Rev Esp Oncol; 1982; 29(4):641-7. PubMed ID: 6085740
[TBL] [Abstract][Full Text] [Related]
26. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
27. [6-Mercaptopurine and methotrexate, rational use in sight after 35 years?].
Bökkerink JP; Schouten TJ; De Abreu RA; Lippens RJ; De Vaan GA; De Bruyn CH; Van Laarhoven JP
Tijdschr Kindergeneeskd; 1984 Aug; 52(4):118-23. PubMed ID: 6593896
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis.
Moore EC; Hurlbert RB; Massia SP
Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791
[TBL] [Abstract][Full Text] [Related]
29. Effects of extracellular purines on cytotoxicity of methotrexate.
Chong L; Ma G; Bartier WA; Tattersall MH
Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
[TBL] [Abstract][Full Text] [Related]
30. Pyrimidine nucleotide and nucleic acid synthesis in human monocytes and macrophages.
Terai C; Carson DA
Exp Cell Res; 1991 Apr; 193(2):375-81. PubMed ID: 1706277
[TBL] [Abstract][Full Text] [Related]
31. Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines.
Musk P; Stowers A; Parsons PG
Biochem Pharmacol; 1990 Feb; 39(4):631-7. PubMed ID: 1689577
[TBL] [Abstract][Full Text] [Related]
32. The influence of ribose 5-phosphate availability on purine synthesis of cultured human lymphoblasts and mitogen-stimulated lymphocytes.
Pilz RB; Willis RC; Boss GR
J Biol Chem; 1984 Mar; 259(5):2927-35. PubMed ID: 6699001
[TBL] [Abstract][Full Text] [Related]
33. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
34. Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia.
van den Berg AA; van Lenthe H; Busch S; de Korte D; Roos D; van Kuilenburg AB; van Gennip AH
Eur J Biochem; 1993 Aug; 216(1):161-7. PubMed ID: 8365402
[TBL] [Abstract][Full Text] [Related]
35. T-lymphocytes from AIDS patients are unable to synthesize ribonucleotides de novo in response to mitogenic stimulation. Impaired pyrimidine responses are already evident at early stages of HIV-1 infection.
Bofill M; Fairbanks LD; Ruckemann K; Lipman M; Simmonds HA
J Biol Chem; 1995 Dec; 270(50):29690-7. PubMed ID: 8530357
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
Taylor IW; Tattersall MH
Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
[TBL] [Abstract][Full Text] [Related]
37. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
38. Consequences of methotrexate inhibition of purine biosynthesis in L5178Y cells.
Hryniuk WM; Brox LW; Henderson JF; Tamaoki T
Cancer Res; 1975 Jun; 35(6):1427-32. PubMed ID: 1055632
[TBL] [Abstract][Full Text] [Related]
39. Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.
Boss GR
Biochem J; 1987 Mar; 242(2):425-31. PubMed ID: 3109390
[TBL] [Abstract][Full Text] [Related]
40. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
